Craft

Advanced
Altimmune

Altimmune

Stock Price

$7

2024-10-28

Market Capitalization

$498.2 M

2024-10-28

Revenue

$41 K

FY, 2025

Altimmune Summary

Company Summary

Overview
Altimmune is a clinical-stage immunotherapeutics company. It is focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of infectious disease.
Type
Public
Status
Active
Founded
1997
HQ
Gaithersburg, MD, US | view all locations
Website
http://www.altimmune.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Vipin K. Garg

    Vipin K. Garg, President, Chief Executive Officer

  • Mitchel Sayare, Chairman of the Board

    • David J. Drutz, Director

      • Richard Eisenstadt

        Richard Eisenstadt, Chief Financial Officer

        LocationsView all

        1 location detected

        • Gaithersburg, MD HQ

          United States

          910 Clopper Rd

        Altimmune Financials

        Summary Financials

        Net income (Q1, 2026)
        ($22.6M)
        Cash (Q1, 2026)
        $97.6M
        EBIT (Q1, 2026)
        ($24.2M)
        Enterprise value
        $435.1M

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2026
        Share price data provided by IEX